NPI: 1225289895 · SPOKANE, WA 99208 · General Acute Care Hospital · NPI assigned 10/01/2008
Authorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
| Authorized Official | ANDERSON, DONALD (ASSISTANT SECREATRY FOR ENROLLMENT) |
| NPI Enumeration Date | 10/01/2008 |
Other providers sharing the same authorized official: ANDERSON, DONALD
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 210,940 | $7.16M |
| 2019 | 219,591 | $8.04M |
| 2020 | 197,848 | $6.77M |
| 2021 | 206,461 | $7.20M |
| 2022 | 183,953 | $5.99M |
| 2023 | 155,264 | $4.41M |
| 2024 | 124,808 | $3.70M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 96361 | Intravenous infusion, hydration; each additional hour | 29,668 | 25,974 | $8.76M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 48,487 | 45,666 | $4.72M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 47,401 | 44,004 | $3.21M |
| S9480 | Intensive outpatient psychiatric services, per diem | 5,519 | 849 | $2.99M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 31,115 | 29,285 | $2.02M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 26,013 | 12,985 | $1.96M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 10,692 | 10,359 | $1.81M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 14,890 | 10,789 | $1.57M |
| J2323 | Injection, natalizumab, 1 mg | 1,114 | 1,010 | $1.37M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 4,446 | 4,326 | $1.25M |
| 70450 | Computed tomography, head or brain; without contrast material | 8,001 | 7,681 | $1.05M |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 2,514 | 2,437 | $961K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 8,695 | 7,829 | $928K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 1,519 | 1,487 | $851K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 9,831 | 9,486 | $719K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 8,533 | 8,198 | $656K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3,800 | 3,686 | $620K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 2,690 | 2,620 | $614K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 3,503 | 2,634 | $581K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 3,139 | 3,053 | $452K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 3,439 | 2,587 | $320K |
| 80053 | Comprehensive metabolic panel | 65,094 | 56,748 | $305K |
| 95806 | 717 | 700 | $292K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 2,406 | 2,307 | $280K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 3,178 | 3,080 | $267K |
| 12001 | 1,128 | 1,123 | $229K | |
| 70496 | 1,522 | 1,483 | $228K | |
| 10061 | 1,106 | 1,061 | $226K | |
| 93971 | 2,628 | 2,547 | $219K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 1,331 | 1,295 | $213K |
| 95782 | 301 | 301 | $209K | |
| J2350 | Injection, ocrelizumab, 1 mg | 30 | 25 | $185K |
| 59025 | Fetal non-stress test | 1,182 | 805 | $184K |
| 96415 | 885 | 689 | $167K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 457 | 439 | $166K |
| 87631 | 3,711 | 3,590 | $163K | |
| 76830 | Ultrasound, transvaginal | 1,870 | 1,835 | $142K |
| G0249 | Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the home and reporting of test results to physician; testing not occurring more frequently than once a week; testing materials, billing units of service include 4 tests | 4,852 | 4,429 | $123K |
| 12011 | 383 | 382 | $95K | |
| 93017 | 970 | 946 | $89K | |
| 10060 | 429 | 418 | $86K | |
| 47562 | 37 | 37 | $81K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 260 | 257 | $74K |
| 12002 | 357 | 355 | $71K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 2,227 | 2,156 | $70K |
| 84484 | 15,002 | 11,837 | $69K | |
| 62323 | 376 | 371 | $67K | |
| 76801 | 922 | 884 | $63K | |
| 27447 | 12 | 12 | $57K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 7,651 | 5,887 | $52K |
| 87040 | 8,449 | 4,291 | $51K | |
| 43248 | 112 | 108 | $50K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 4,997 | 4,612 | $48K |
| 76937 | 656 | 603 | $48K | |
| 95800 | 474 | 474 | $47K | |
| 93975 | 1,114 | 1,088 | $45K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 9,021 | 7,878 | $44K |
| G0378 | Hospital observation service, per hour | 5,294 | 2,463 | $41K |
| 84145 | 4,760 | 4,446 | $37K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 1,308 | 1,281 | $36K |
| 70498 | 1,314 | 1,276 | $35K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 403 | 399 | $33K |
| 90715 | 1,921 | 1,903 | $33K | |
| 95811 | 80 | 78 | $32K | |
| 83605 | 6,390 | 5,270 | $32K | |
| 70486 | 1,307 | 1,281 | $29K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3,112 | 3,083 | $29K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 1,070 | 1,025 | $28K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 64,879 | 56,995 | $26K |
| 83880 | 4,781 | 4,448 | $25K | |
| 96367 | 1,429 | 1,014 | $25K | |
| 85379 | 4,689 | 4,575 | $24K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 5,048 | 4,901 | $24K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2,254 | 2,213 | $23K |
| 64483 | 42 | 41 | $22K | |
| 36415 | Collection of venous blood by venipuncture | 17,475 | 14,516 | $21K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1,707 | 1,676 | $21K |
| 72125 | Computed tomography, cervical spine; without contrast material | 2,979 | 2,890 | $19K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 23,408 | 21,805 | $18K |
| 80050 | General health panel | 3,254 | 3,200 | $17K |
| 76770 | 177 | 168 | $16K | |
| 97802 | 216 | 214 | $14K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 662 | 351 | $13K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1,674 | 1,650 | $10K |
| 70544 | 127 | 127 | $10K | |
| 85027 | 11,633 | 10,213 | $10K | |
| 87641 | 1,072 | 1,049 | $10K | |
| 93970 | 110 | 106 | $10K | |
| 84443 | Thyroid stimulating hormone (TSH) | 6,117 | 5,870 | $10K |
| 86140 | 5,799 | 5,137 | $10K | |
| 94060 | 247 | 240 | $10K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 35,152 | 31,699 | $10K |
| 83735 | 8,990 | 7,001 | $9K | |
| 71046 | Radiologic examination, chest; 2 views | 10,972 | 10,599 | $9K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 299 | 294 | $9K |
| P9045 | Infusion, albumin (human), 5%, 250 ml | 36 | 32 | $9K |
| 36430 | 142 | 107 | $8K | |
| 71045 | Radiologic examination, chest; single view | 10,349 | 9,797 | $7K |
| 88307 | 509 | 497 | $7K | |
| 29125 | 31 | 29 | $7K | |
| 97803 | 193 | 160 | $7K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 30,180 | 25,940 | $6K |
| 97161 | 206 | 201 | $6K | |
| 70491 | 68 | 67 | $5K | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 1,985 | 1,948 | $5K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 473 | 464 | $5K |
| 64415 | 47 | 45 | $5K | |
| 80306 | 8,591 | 8,197 | $5K | |
| 86780 | 388 | 383 | $4K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 11,088 | 9,765 | $4K |
| 97597 | 91 | 25 | $4K | |
| 85652 | 1,607 | 1,441 | $4K | |
| 76870 | 52 | 52 | $4K | |
| 94729 | 217 | 210 | $4K | |
| 43235 | 13 | 12 | $4K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 525 | 515 | $4K |
| 82728 | 731 | 701 | $4K | |
| 80143 | 1,057 | 1,018 | $4K | |
| 85610 | 28,911 | 15,659 | $4K | |
| 81001 | 24,778 | 23,229 | $4K | |
| 82962 | 22,471 | 15,317 | $3K | |
| 87581 | 473 | 464 | $3K | |
| 87486 | 472 | 463 | $3K | |
| 84100 | 2,089 | 1,511 | $3K | |
| 84439 | 1,478 | 1,437 | $3K | |
| 80061 | Lipid panel | 908 | 896 | $3K |
| 85007 | 1,049 | 904 | $3K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | 12 | 12 | $3K |
| 94726 | 162 | 156 | $3K | |
| Q0247 | Injection, sotrovimab, 500 mg | 12 | 12 | $3K |
| 45381 | 69 | 68 | $3K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 12 | 12 | $3K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 34,708 | 29,293 | $2K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 8,326 | 8,098 | $2K |
| M0247 | Intravenous infusion, sotrovimab, includes infusion and post administration monitoring | 12 | 12 | $2K |
| 83690 | 19,710 | 18,064 | $2K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 14 | 14 | $2K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 17,070 | 16,278 | $2K |
| 80179 | 1,015 | 983 | $2K | |
| 90686 | 239 | 230 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2,572 | 2,477 | $2K |
| 73630 | 2,079 | 1,945 | $2K | |
| 73610 | 2,182 | 2,077 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 600 | 581 | $2K |
| 96376 | 10,362 | 8,572 | $2K | |
| 97162 | 97 | 94 | $2K | |
| 84702 | 2,294 | 2,116 | $2K | |
| 72100 | 1,539 | 1,510 | $2K | |
| J1170 | Injection, hydromorphone, up to 4 mg | 20,381 | 15,354 | $2K |
| 74174 | 13 | 13 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 6,513 | 6,213 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | 711 | 694 | $2K |
| 73030 | 2,049 | 1,920 | $2K | |
| 86850 | 2,112 | 1,890 | $2K | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 991 | 891 | $2K |
| 74018 | 1,001 | 960 | $1K | |
| 83550 | 431 | 416 | $1K | |
| 83540 | 608 | 589 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 20,226 | 18,332 | $1K |
| 73130 | 1,882 | 1,795 | $1K | |
| 81025 | 19,333 | 18,482 | $1K | |
| 73502 | 1,212 | 1,090 | $1K | |
| 86901 | 2,204 | 1,944 | $1K | |
| 74019 | 614 | 598 | $1K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 15,301 | 11,353 | $1K |
| 81003 | 18,466 | 17,521 | $1K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2,253 | 2,213 | $1K |
| 87070 | 1,830 | 1,711 | $1K | |
| J2704 | Injection, propofol, 10 mg | 15,316 | 14,587 | $944.89 |
| 82077 | 5,999 | 5,572 | $926.34 | |
| 87075 | 1,506 | 1,402 | $921.43 | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 12 | 12 | $892.14 |
| 73560 | 776 | 753 | $891.23 | |
| J1815 | Injection, insulin, per 5 units | 3,914 | 1,896 | $882.84 |
| 86900 | 2,140 | 1,881 | $868.85 | |
| 82550 | 1,570 | 1,265 | $855.23 | |
| 73562 | 1,122 | 1,098 | $847.03 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 29,877 | 26,311 | $824.72 |
| 87205 | 2,091 | 1,913 | $812.95 | |
| J3490 | Unclassified drugs | 1,327 | 1,204 | $796.10 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 14,850 | 13,444 | $783.54 |
| 82570 | 571 | 509 | $782.04 | |
| 86923 | 74 | 63 | $778.89 | |
| 73140 | 590 | 558 | $675.64 | |
| 80069 | 194 | 147 | $662.93 | |
| 73590 | 673 | 617 | $659.36 | |
| 82805 | 1,626 | 1,430 | $653.98 | |
| 73110 | 1,238 | 1,192 | $649.12 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 9,754 | 9,301 | $598.82 |
| 89051 | 84 | 68 | $594.23 | |
| 87077 | 2,238 | 2,160 | $565.31 | |
| 87186 | 3,316 | 3,205 | $555.34 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 7,544 | 7,232 | $522.47 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 6,282 | 5,418 | $505.29 |
| 85730 | 3,105 | 2,926 | $486.94 | |
| 84703 | 1,465 | 1,425 | $483.53 | |
| 87088 | 2,117 | 2,039 | $479.01 | |
| 81002 | 1,511 | 1,432 | $445.82 | |
| 84156 | 271 | 244 | $413.40 | |
| 73080 | 175 | 170 | $407.71 | |
| 71101 | 678 | 659 | $383.32 | |
| J7050 | Infusion, normal saline solution, 250 cc | 11,510 | 6,712 | $382.44 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 3,006 | 2,604 | $373.05 |
| 82607 | 80 | 79 | $367.36 | |
| 87420 | 21 | 21 | $365.80 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 7,065 | 6,131 | $351.10 |
| 87634 | 410 | 401 | $339.13 | |
| 73564 | 270 | 260 | $312.42 | |
| A9270 | Non-covered item or service | 11,784 | 3,936 | $303.01 |
| 87400 | 28 | 14 | $281.92 | |
| 73090 | 328 | 305 | $280.82 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 6,931 | 5,451 | $276.70 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 4,015 | 3,696 | $248.56 |
| J3480 | Injection, potassium chloride, per 2 meq | 1,204 | 813 | $235.18 |
| 87210 | 936 | 921 | $229.79 | |
| 88342 | 1,295 | 1,251 | $207.03 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 8,761 | 7,584 | $170.48 |
| 84550 | 283 | 272 | $164.32 | |
| 82784 | 72 | 54 | $163.49 | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 3,745 | 3,640 | $145.80 |
| C1769 | Guide wire | 1,384 | 1,296 | $141.59 |
| 90656 | 15 | 15 | $133.62 | |
| 84112 | 41 | 40 | $133.48 | |
| 87340 | 50 | 48 | $130.69 | |
| 87081 | 288 | 287 | $127.03 | |
| 85018 | 258 | 189 | $119.04 | |
| 87147 | 315 | 307 | $116.84 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 1,651 | 1,256 | $114.49 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 1,937 | 1,876 | $104.07 |
| 86803 | 29 | 29 | $102.87 | |
| 82105 | 25 | 25 | $102.67 | |
| 73660 | 28 | 28 | $94.20 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 1,756 | 844 | $90.87 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 1,084 | 1,067 | $81.12 |
| 80164 | 15 | 12 | $79.97 | |
| 85014 | 149 | 102 | $76.35 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 6,983 | 5,712 | $72.39 |
| 82945 | 27 | 27 | $71.54 | |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 285 | 255 | $70.22 |
| 82565 | 39 | 37 | $70.00 | |
| J2060 | Injection, lorazepam, 2 mg | 4,372 | 3,693 | $68.96 |
| 86364 | 12 | 12 | $65.08 | |
| 88304 | 948 | 933 | $64.20 | |
| 84157 | 31 | 29 | $52.75 | |
| 80076 | 15 | 12 | $50.69 | |
| 99152 | 56 | 56 | $50.43 | |
| 87493 | 39 | 38 | $46.74 | |
| 73070 | 30 | 24 | $40.53 | |
| 82746 | 14 | 13 | $36.57 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 2,495 | 2,153 | $32.29 |
| 82010 | 341 | 292 | $31.33 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 1,757 | 1,613 | $30.59 |
| 82803 | 60 | 57 | $29.31 | |
| 86592 | 29 | 25 | $27.86 | |
| A9585 | Injection, gadobutrol, 0.1 ml | 177 | 165 | $27.20 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 2,913 | 1,714 | $22.32 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 1,846 | 1,780 | $22.17 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 36 | 36 | $17.84 |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 119 | 117 | $17.51 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 4,328 | 3,752 | $11.87 |
| J8540 | Dexamethasone, oral, 0.25 mg | 1,110 | 693 | $11.40 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 716 | 710 | $10.62 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 1,449 | 1,364 | $10.34 |
| 36600 | 26 | 24 | $9.15 | |
| 99153 | Mod sedat endo service >5yrs | 300 | 299 | $8.01 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 4,811 | 4,624 | $5.20 |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 745 | 695 | $4.07 |
| 36591 | 29 | 29 | $3.93 | |
| J1630 | Injection, haloperidol, up to 5 mg | 1,289 | 1,060 | $1.98 |
| J1940 | Injection, furosemide, up to 20 mg | 312 | 224 | $1.74 |
| J1644 | Injection, heparin sodium, per 1000 units | 2,172 | 909 | $0.08 |
| C9113 | Injection, pantoprazole sodium, per vial | 1,813 | 1,387 | $0.04 |
| J3370 | Injection, vancomycin hcl, 500 mg | 2,288 | 1,647 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 15,935 | 13,106 | $0.00 |
| J0692 | Injection, cefepime hydrochloride, 500 mg | 379 | 287 | $0.00 |
| J1245 | Injection, dipyridamole, per 10 mg | 130 | 123 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 143 | 139 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 246 | 222 | $0.00 |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 541 | 304 | $0.00 |
| 87806 | 148 | 147 | $0.00 | |
| J0744 | Injection, ciprofloxacin for intravenous infusion, 200 mg | 95 | 86 | $0.00 |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 716 | 705 | $0.00 |
| C1776 | Joint device (implantable) | 174 | 173 | $0.00 |
| 96417 | 123 | 79 | $0.00 | |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 45 | 43 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 305 | 297 | $0.00 |
| C1758 | Catheter, ureteral | 42 | 41 | $0.00 |
| J0688 | Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg | 81 | 76 | $0.00 |
| J3415 | Injection, pyridoxine hcl, 100 mg | 67 | 56 | $0.00 |
| M0222 | Intravenous injection, bebtelovimab, includes injection and post administration monitoring | 60 | 60 | $0.00 |
| 29824 | 13 | 13 | $0.00 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 207 | 177 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 15 | 13 | $0.00 |
| 72050 | 12 | 12 | $0.00 | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 14 | 13 | $0.00 |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | 903 | 894 | $0.00 |
| J3411 | Injection, thiamine hcl, 100 mg | 734 | 567 | $0.00 |
| J1790 | Injection, droperidol, up to 5 mg | 179 | 172 | $0.00 |
| 74420 | 39 | 36 | $0.00 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 603 | 505 | $0.00 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 584 | 485 | $0.00 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 850 | 829 | $0.00 |
| C1726 | Catheter, balloon dilatation, non-vascular | 24 | 24 | $0.00 |
| J1836 | Injection, metronidazole, 10 mg | 192 | 155 | $0.00 |
| J0456 | Injection, azithromycin, 500 mg | 44 | 37 | $0.00 |
| J2785 | Injection, regadenoson, 0.1 mg | 17 | 17 | $0.00 |
| S2900 | Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) | 12 | 12 | $0.00 |
| C1781 | Mesh (implantable) | 57 | 57 | $0.00 |
| C1889 | Implantable/insertable device, not otherwise classified | 298 | 284 | $0.00 |
| J0280 | Injection, aminophyllin, up to 250 mg | 143 | 135 | $0.00 |
| 89060 | 14 | 12 | $0.00 | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 108 | 51 | $0.00 |
| 96368 | 122 | 67 | $0.00 | |
| 73552 | 13 | 12 | $0.00 | |
| J2470 | Injection, pantoprazole sodium, 40 mg | 56 | 48 | $0.00 |
| C2617 | Stent, non-coronary, temporary, without delivery system | 41 | 41 | $0.00 |
| 86308 | 14 | 13 | $0.00 | |
| A9503 | Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | 27 | 25 | $0.00 |
| J7999 | Compounded drug, not otherwise classified | 68 | 59 | $0.00 |
| 88341 | 13 | 13 | $0.00 |